240 related articles for article (PubMed ID: 30314372)
1. Molecular Features Distinguish Gastric Cancer Subtypes.
De Re V
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314372
[TBL] [Abstract][Full Text] [Related]
2. Gastric Cancer Diagnosis: From Imaging Techniques to Biochemical Biomarkers.
Tavakoli F; Khatami SS; Momeni F; Azadbakht J; Ghasemi F
Curr Mol Med; 2021; 21(5):355-375. PubMed ID: 32888267
[TBL] [Abstract][Full Text] [Related]
3. Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer.
Shu J; Yu H; Li X; Zhang D; Liu X; Du H; Zhang J; Yang Z; Xie H; Li Z
Oncotarget; 2017 May; 8(22):35718-35727. PubMed ID: 28415698
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of circulating tumor cells in gastric cancer patients.
Zhou J; Ma X; Bi F; Liu M
Oncotarget; 2017 Apr; 8(15):25713-25720. PubMed ID: 28147337
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnostics in esophageal and gastric neoplasms.
Zulfiqar M; Bhalla A; Weindel M; Shidham VB
Clin Lab Med; 2013 Dec; 33(4):867-73. PubMed ID: 24267191
[TBL] [Abstract][Full Text] [Related]
6. Gastric Cancer: Recent Molecular Classification Advances, Racial Disparity, and Management Implications.
Sanjeevaiah A; Cheedella N; Hester C; Porembka MR
J Oncol Pract; 2018 Apr; 14(4):217-224. PubMed ID: 29641950
[TBL] [Abstract][Full Text] [Related]
7. A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer.
Li W; Jia H; Wang J; Guan H; Li Y; Zhang D; Tang Y; Wang TD; Lu S
Oncotarget; 2017 May; 8(18):30063-30076. PubMed ID: 28415792
[TBL] [Abstract][Full Text] [Related]
8. Potential Biomarkers in Diagnosis of Human Gastric Cancer.
Zhang Z; Dou M; Yao X; Tang H; Li Z; Zhao X
Cancer Invest; 2016; 34(3):115-22. PubMed ID: 26934336
[TBL] [Abstract][Full Text] [Related]
9. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer.
Sawaki K; Kanda M; Kodera Y
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):657-670. PubMed ID: 29902383
[TBL] [Abstract][Full Text] [Related]
10. Review of recent molecular landscape knowledge of gastric cancer.
Shimizu D; Kanda M; Kodera Y
Histol Histopathol; 2018 Jan; 33(1):11-26. PubMed ID: 28447336
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications.
Gullo I; Carneiro F; Oliveira C; Almeida GM
Pathobiology; 2018; 85(1-2):50-63. PubMed ID: 28618420
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation in gastric cancer.
Li Y; Liang J; Hou P
Clin Chim Acta; 2015 Aug; 448():124-32. PubMed ID: 26148722
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
Yang Z; Guo X; Li G; Shi Y; Li L
Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
[TBL] [Abstract][Full Text] [Related]
14. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine.
Wang S; Yuan L
Biosci Trends; 2016 Jul; 10(3):171-80. PubMed ID: 27251446
[TBL] [Abstract][Full Text] [Related]
15. Individual risk stratification of gastric cancer: evolving concepts and their impact on clinical practice.
Rugge M; Capelle LG; Fassan M
Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1043-53. PubMed ID: 25439070
[TBL] [Abstract][Full Text] [Related]
16. Lgr5High/DCLK1High phenotype is more common in early stage and intestinal subtypes of gastric carcinomas.
Kalantari E; Asadi Lari MH; Roudi R; Korourian A; Madjd Z
Cancer Biomark; 2017 Dec; 20(4):563-573. PubMed ID: 28946555
[TBL] [Abstract][Full Text] [Related]
17. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
Shekari N; Baradaran B; Shanehbandi D; Kazemi T
Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
[TBL] [Abstract][Full Text] [Related]
18. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.
Mohri Y; Toiyama Y; Kusunoki M
Expert Rev Proteomics; 2016 Dec; 13(12):1131-1139. PubMed ID: 27744719
[TBL] [Abstract][Full Text] [Related]
19. The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice.
Abbas M; Habib M; Naveed M; Karthik K; Dhama K; Shi M; Dingding C
Biomed Pharmacother; 2017 Nov; 95():1082-1090. PubMed ID: 28922727
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic analysis reveals that proteins required for fatty acid metabolism may serve as diagnostic markers for gastric cancer.
Jiang Z; Shen H; Tang B; Yu Q; Ji X; Wang L
Clin Chim Acta; 2017 Jan; 464():148-154. PubMed ID: 27884752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
